Lv01
0 积分 2023-03-28 加入
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
3小时前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
3小时前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
In vivo CAR T cells move into clinical trials
3个月前
已完结
In Vitro and In Vivo Activity of a Lipid Nanoparticle System for the In Vivo Generation of CAR T Cells
4个月前
已完结
In Vitro and In Vivo Activity of a Lipid Nanoparticle System for the In Vivo Generation of CAR T Cells
4个月前
已关闭
Exploring the Effects of Incorporating Different Bioactive Phospholipids into Messenger Ribonucleic Acid Lipid Nanoparticle (mRNA LNP) Formulations
5个月前
已关闭
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
5个月前
已完结
Fully human CD19-specific chimeric antigen receptors for T-cell therapy
5个月前
已完结
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
5个月前
已完结
皖公网安备34019202002308
